Memphis Pharmaceuticals (MPCI.CA) - Company’s Response on the Central Auditing Organization Report
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The company’s response to the report of the Central Auditing Organization on the financial statements for the financial period ending on 30/09/2023.
Company's Response (739 KB)
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The company’s response to the report of the Central Auditing Organization on the financial statements for the financial period ending on 30/09/2023.
Company's Response (739 KB)
Comments